ArticleCarcinogenesis2025

Olfactomedin 4 promotes gastric cancer cell G2/M progression and serves as a therapeutic target in gastric adenocarcinoma.

Wenli Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.